Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin for Gardnerella Vaginalis Colonization
NCT03211156Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bacterial vaginosis (BV) comparing Amoxicillin Arm with Placebo Arm (2 arms). Primary endpoint: Proportion of Participants With Eradication of Gardnerella Vaginalis (GV). Started Sep 2017; status: completed.
02
Drugs
amoxicillin
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT03211156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03211156.